FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response - FDA Press Releases

FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response

from Food and Drug Administration--Press Releases http://ift.tt/2D0hhBd
via IFTTT